Kestrel

Aseptically Prepared Systemic Anti-Cancer Therapy Medicines

Mid South Essex NHS Foundation Trust · published Mon 26 Oct 2026

In plain English

Reading the notice and writing a summary. This takes a few seconds the first time.

The documents are on Jaggaer, where the bid is sent too. It's free to register there.

The notice as published

This framework agreement is for the supply of a range of aseptically prepared, batch manufactured systemic anti-cancer therapy drugs in ready-to-administer presentations and agreed dose bands. The framework agreement will also cover the manufacturing and supply of patient specific systemic anti-cancer therapy drugs and medicines used in CIVAs.